Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
Journal of the American College of Cardiology|July 10, 1999
Remote telemedical interpretation of neonatal echocardiograms: impact on clinical management in a primary care settingG R Randolph, D J Hagler, B K Khandheria, et al.Cancer Research|June 1, 1980
Large-capacity separation of malignant cells and lymphocytes from the Furth mast cell tumor in a reorienting zonal rotorC L Green, T P Pretlow, K A Tucker, et al.The Journal of Biological Chemistry|August 15, 1990
Three-dimensional structure of thymidine phosphorylase from Escherichia coli at 2.8 A resolutionM R Walter, W J Cook, L B Cole, et al.Molecular and Cellular Biology|April 1, 1992
Glucose repression of the yeast ADH2 gene occurs through multiple mechanisms, including control of the protein synthesis of its transcriptional activator, ADR1R C Vallari, W J Cook, D C Audino, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|November 16, 2006
Discovery of highly potent small molecule kallikrein inhibitorsJ Zhang, R Krishnan, C S Arnold, et al.European Journal of Medicinal Chemistry|December 20, 2023
Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerasesMinwan Wu, Satish Vadlakonda, Yahya El-Kattan, et al.Protein Science : a Publication of the Protein Society|June 1, 1997
Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activityG S Prasad, R Radhakrishnan, D T Mitchell, et al.Transplantation|February 7, 2001
Postransplant lymphoproliferative disorder localized near the allograft in renal transplantationC E Kew, R Lopez-Ben, J K Smith, et al.Bioorganic & Medicinal Chemistry|October 22, 2022
Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitorsWeihe Zhang, Minwan Wu, Satish Vadlakonda, et al.Bioorganic & Medicinal Chemistry|October 8, 2022
Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbonWeihe Zhang, Satish Vadlakonda, Minwan Wu, et al.Pageof 16